Edition:
United States

Natera Inc (NTRA.OQ)

NTRA.OQ on NASDAQ Stock Exchange Global Select Market

9.87USD
15 Dec 2017
Change (% chg)

$0.34 (+3.57%)
Prev Close
$9.53
Open
$9.59
Day's High
$9.88
Day's Low
$9.45
Volume
185,483
Avg. Vol
67,639
52-wk High
$14.69
52-wk Low
$7.38

Summary

Name Age Since Current Position

Matthew Rabinowitz

44 2015 Chairman of the Board, President, Chief Executive Officer, Co-Founder

Jonathan Sheena

44 2007 Co-Founder, Chief Technology Officer, Director

Michael Brophy

37 2017 Chief Financial Officer

Roelof Botha

43 2007 Lead Independent Director

Todd Cozzens

61 2007 Independent Director

Edward Driscoll

64 2007 Independent Director

James Healy

52 2014 Independent Director

Gail Marcus

60 2017 Independent Director

John Steuart

55 2007 Independent Director

Biographies

Name Description

Matthew Rabinowitz

Dr. Matthew Rabinowitz, Ph.D. serves as Chairman of the Board, President, Chief Executive Officer and Co-Founder of the Company. Dr. Rabinowitz is a co-founder of our company and has served as a member of our board of directors and as our Chief Executive Officer since 2005 and as Chairman of our board of directors since May 2015. Prior to co-founding our company, Dr. Rabinowitz served from 2000 to 2003 as chief executive officer and from 2003 to 2007 as chief technology officer of Rosum Corporation, a location services technology company. Dr. Rabinowitz has multiple publications in signal processing, machine learning, bio-informatics, and high-throughput genetic testing. He received the Scott Helt Memorial Award from the Institute of Electrical and Electronics Engineers and received Technology Pioneer Awards from the World Economic Forum for founding Rosum Corporation and Natera. He currently serves on the board of directors of a private company. Dr. Rabinowitz holds a Bachelor of Science degree in Engineering and Physics, a Master of Science in Electrical Engineering, and a Ph.D. in Electrical Engineering, from Stanford University.

Jonathan Sheena

Mr. Jonathan Sheena serves as Co-Founder, Chief Technology Officer and Director of the Company. In 1999, Mr. Sheena co-founded PhoneSpots, Inc. (formerly PocketThis, Inc.), a mobile technology company serving mobile carriers worldwide. Mr. Sheena holds a Bachelor of Science in Electrical Engineering and Computer Science, and a Master of Engineering in Electrical Engineering and Computer Science, from the Massachusetts Institute of Technology.

Michael Brophy

Mr. Michael Burkes Brophy serves as Chief Financial Officer of the Company. Mr. Brophy has served as our Chief Financial Officer since February 2017. Previously, he served as our Senior Vice President, Finance and Investor Relations since September 2016, and prior to that, as our Vice President, Corporate Development and Investor Relations since September 2015. Prior to joining Natera, Mr. Brophy served as an executive director from January 2014 to September 2015, and as a vice president from 2011 to 2013, in the investment banking division at Morgan Stanley where he focused on advising corporate clients in the life science tools and diagnostics sector. Mr. Brophy holds an M.B.A. from the University of California, Los Angeles and a Bachelor of Science in Economics from the United States Air Force Academy.

Roelof Botha

Mr. Roelof Frederick Botha serves as lead independent director of the Company. Mr. Botha has served as a member of our board of directors since 2007. Mr. Botha has been with Sequoia Capital, a venture capital firm, since 2003, and has been a managing member of Sequoia Capital Operations, LLC since 2007. From 2000 to 2003, Mr. Botha served in a number of roles at PayPal, Inc., ultimately as the chief financial officer. Mr. Botha currently serves on the board of directors of Square, Inc., a provider of payments, financial and marketing services, and a number of private companies. Mr. Botha holds a Bachelor of Science in Actuarial Science, Economics, and Statistics from the University of Cape Town and an M.B.A. from Stanford University.

Todd Cozzens

Mr. Todd C. Cozzens is an Independent Director of the Company. Mr. Cozzens served as a member of our board of directors since 2011. Mr. Cozzens has been a managing partner at Leerink Capital Partners, an asset management firm, since 2015. Mr. Cozzens was a consultant with Sequoia Capital, a venture capital firm, from 2012 to 2015. From 2010 to 2012, Mr. Cozzens served as chief executive officer of Optum Accountable Care Solutions, a business unit of Optum/UnitedHealth Group. From 2000 to 2010, Mr. Cozzens served as chief executive officer of Picis Inc., a provider of electronic medical record software to hospitals, until its acquisition by the UnitedHealth Group in 2010. Mr. Cozzens currently serves on the boards of directors of a number of private companies. Mr. Cozzens holds a Bachelor of Arts degree from Marquette University, and completed the Program for Management Development at Harvard University.

Edward Driscoll

Dr. Edward C. Driscoll Jr. Ph.D. is an Independent Director of the Company. Dr. Driscoll has served as a member of our board of directors since 2007. Dr. Driscoll has been a partner with Decheng Capital, a venture capital firm, since October 2016, and has been a partner with Claremont Creek Ventures, a venture capital firm, since 2006, first as a venture partner, then a technology partner, and, since 2012, a director. Dr. Driscoll currently serves on the boards of directors of a number of private companies. In addition, from 2005 to 2013, Dr. Driscoll was an angel investor with Health Tech Capital, Silicom Ventures and Sand Hill Angels. From December 1995 to April 2005, Dr. Driscoll was founder, president and chief executive officer of Be Here Corporation, an internet, broadcast and videoconferencing technology company. From June 1993 to June 1995, Dr. Driscoll served as chief executive officer of Focus Surgery, Inc., a non-invasive surgical equipment company. From December 1987 to June 1993, Dr. Driscoll held various roles at Diasonics, a digital imaging and medical device company. Dr. Driscoll holds a Bachelor of Arts in Photography and Computer Science from the University of Pennsylvania, a Master of Architecture and Master of Landscape Architecture from Harvard University , and a Ph.D. in Digital Imaging from Stanford University.

James Healy

Dr. James I. Healy, M.D. PhD. is an Independent Director of the Company . He served as a member of our board of directors since November 2014. Dr. Healy has been a general partner at Sofinnova Ventures, a venture capital firm, since 2000. Prior to Sofinnova Ventures, Dr. Healy held various positions at Sanderling Ventures, a venture capital firm, Bayer Healthcare Pharmaceuticals (as successor to Miles Laboratories), a research based pharmaceutical company and ISTA Pharmaceuticals, Inc., a company specializing in ophthalmic pharmaceutical products. Dr. Healy is currently on the board of directors of Ascendis Pharma A/S, a clinical-stage biopharmaceutical company; Auris Medical Holding AG, a specialty pharmaceutical company focused on tinnitus; Coherus BioSciences, Inc., a biologics platform company; Edge Therapeutics, a clinical-stage biotechnology company; Obseva SA, a clinical-stage biopharmaceutical company; and several private companies. Previously, Dr. Healy served as a board member of Anthera Pharmaceuticals, Inc., a biopharmaceutical company focused on inflammation and autoimmune diseases; Amarin Corporation plc, a commercial-stage biopharmaceutical company; Durata Therapeutics, Inc., a pharmaceutical company focused on infectious and acute diseases; InterMune, Inc., a biotechnology company focused on orphan fibrotic pulmonary disease; KaloBios Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of monoclonal antibody therapeutics; Hyperion Therapeutics, Inc., a commercial-stage orphan disease company; and a number of private companies. Dr. Healy holds a Bachelor of Arts in Molecular Biology and Scandinavian Studies from the University of California at Berkeley, and an M.D. and Ph.D. in Immunology from Stanford University School of Medicine.

Gail Marcus

Ms. Gail Boxer Marcus is an Independent Director of the Company. She joined our board of directors in March 2017. Ms. Marcus has served as a consultant and practice leader in the healthcare consulting practice of Exceptional Leaders International, a consulting company, since 2015, and as an Assistant Professor & Director of the Global Healthcare Management and Biomedical Informatics programs at the Massachusetts College of Pharmacy and Health Sciences since 2016. From 2012 to 2015, Ms. Marcus served as Chief Executive Officer and President of Calloway Laboratories, a provider of clinical toxicology laboratory services. Prior to that, Ms. Marcus held a variety of leadership roles with diagnostics, pharmacy benefit management and managed care companies. Ms. Marcus currently serves on the boards of directors of a private company and a non-profit organization, and sits on the Centers for Medicare & Medicaid Services Advisory Panel on Clinical Diagnostic Laboratory Tests. Our board of directors believes that Ms. Marcus is qualified to serve as a director based on her financial and managerial experience and service on other boards of directors. Ms. Marcus holds a Bachelor of Art in Spanish and Mathematics from Wesleyan University, an M.S.E. in Computer and Information Sciences from the University of Pennsylvania Moore School of Engineering, an M.B.A. from the Wharton School of the University of Pennsylvania, and is pursuing a Doctorate of Health Administration from the Medical University of South Carolina.

John Steuart

Mr. John D. Steuart is an Independent Director of the Company. Mr. Steuart has been a managing director at Prolog Ventures, a venture capital firm, since 2013. From 2012 to 2013, Mr. Steuart served as an independent consultant. From 2004 to 2012, Mr. Steuart served as a managing director at Claremont Creek Ventures, a venture capital firm. Mr. Steuart currently serves on the boards of directors of a number of private companies. Mr. Steuart holds a Bachelor of Science degree in Economics from the University of California, Berkeley.

Basic Compensation